Diaceutics Names Steve Vitale Managing Director of Analytics, Insights and Strategy Division | Diaceutics

Diaceutics Names Steve Vitale Managing Director of Analytics, Insights and Strategy Division

Appointment Supports Pharma’s Growing Demand for Personalized Medicine related Intelligence and Strategy

Parsippany, NJ, November 18, 2015 – Diaceutics, a dedicated integrator in personalized and precision medicine, enabling the effective combination of therapies and diagnostics into the treatment pathway, today announced industry veteran Steve Vitale has joined the company to lead its Analytics, Insights and Strategy (AIS) division. Mr. Vitale comes to the Diaceutics from TGaS Advisors, LLC where he was Head of the TGaS Marketing benchmark solution.

“We are very excited to add someone of Steve’s caliber and experience to our leadership team,” said Peter Keeling, CEO of the Diaceutics. “His diverse background and proven track record both within pharma and providing solutions to pharma – specifically understanding what is needed to successfully launch a targeted therapy in today’s global marketplace – is a big win for Diaceutics and our clients. Steve is a natural choice to lead our Analytics, Insights and Strategy division.”

With more than 20 years of experience, Mr. Vitale has held several senior roles at GlaxoSmithKline including Innovation Director, US Vaccines, where he spearheaded the creation of the innovation function and drove development of novel services and solutions to remove barriers customers face throughout the immunization process; Marketing Director, Hib / Meningitis Vaccines, where he launched Hiberix® in the US market and led all pre-commercial and marketing activities supporting the MenHibrix® launch. Mr. Vitale also served as Director, Global Commercial Strategy, Cardiovascular / Metabolic where he drove commercial assessments, evolution of product life cycle and market development opportunities for the diabetes franchise.

“The need for increasingly advanced analytics, deeper insights and formal strategies around targeted therapy launches is becoming more and more critical as pharma’s pipelines become more and more targeted,” said Vitale. “The Diaceutics has been leading the way in terms of helping pharma companies understand the challenging dynamics of targeted therapy launches and I look forward to bringing my experience and knowledge to our AIS division.”

Mr. Vitale has an M.BA. from The Tepper School of Business at Carnegie Mellon University in Pittsburgh, PA and BA in Political Science from Amherst College in Amherst, MA.

About Diaceutics
Diaceutics is transforming an industry model by enabling pharmaceutical companies to accelerate their market penetration and achieve a better return on new therapies by helping them to revolutionise their patient testing. It does this by providing insights generated from its real-time testing data from its worldwide laboratory network, helping Pharma to understand and leverage the diagnostic landscape and deploy initiatives that aid patient diagnosis. The company has experience of more than 300 precision medicine projects and works with 31 of the world’s top 35 pharmaceutical companies. The company employs a leading global group of experts from the laboratory, diagnostic and pharmaceutical industries.

  • Proven global market leader with experience of 300+ precision medicine projects
  • We have helped launch 6 out of the last 12 targeted oncology brands
  • Extensive coverage of Top 10 global markets: US, France, Germany, UK, Italy, Spain, Brazil, China, Russia, Australia
  • Estimates indicate having improved testing for over 500,000 patients globally
  • We draw data from a global network of over 2,500 laboratories to facilitate diagnostic insights
  • We employ a leading global group of experts from the laboratory, diagnostic and pharmaceutical industries

Media Contact
Rebecca McKnight
Tel: +353 1 215 7677
Email: rebecca@comit.ie
For more information, visit www.diaceutics.com or follow Diaceutics on Twitter, LinkedIn or Facebook

Latest Blogs

Latest Blogs